Levocarnitine and Profen drug interactions - a phase IV clinical study of FDA data
Summary:
Drug interactions are reported among people who take Levocarnitine (levocarnitine) and Profen (ibuprofen). Common drug interactions include urinary tract infection among females and seizure among males.
The phase IV clinical study analyzes what interactions people have when they take Levocarnitine and Profen. It is created by eHealthMe based on reports of 148 people who take the same drugs from the FDA, and is updated regularly.
What is Levocarnitine?
Levocarnitine has active ingredients of levocarnitine. It is often used in mitochondrial myopathy. eHealthMe is studying from 3,332 Levocarnitine users. Check the latest studies of Levocarnitine.
What is Profen?
Profen has active ingredients of ibuprofen. It is often used in pain. eHealthMe is studying from 245,311 Profen users. Check the latest studies of Profen.
eHealthMe: drug outcomes in the real world
eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.
148 people who take Levocarnitine and Profen together, and have interactions are studied.
What are the common drug interactions of Levocarnitine and Profen, by gender? *
What are the common drug interactions of Levocarnitine and Profen, by age (0-1 to 60+)? *
What are the existing conditions these people have? *
* Approximation only. Some reports may have incomplete information.
Do you take Levocarnitine and Profen?
- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, side effects of, and alternative drugs to the 2 drugs:
- Levocarnitine (3,332 reports)
- Profen (245,311 reports)
Browse all drug interactions of Levocarnitine and Profen:
a b c d e f g h i j k l m n o p q r s t u v w x y zSub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Levocarnitine:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all side effects of Profen:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Levocarnitine and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Profen and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zRelated publications that referenced our studies
- Moslim MA, Sodeman TC, Nawras AT, "A Case of Suggested Ibuprofen-Induced Acute Pancreatitis", American journal of therapeutics, 2016 Nov .
- Moslim MA, Sodeman TC, Nawras AT, "A Case of Suggested Ibuprofen-Induced Acute Pancreatitis", American journal of therapeutics, 2016 Nov .
How the study uses the data?
The study uses data from the FDA. It is based on levocarnitine and ibuprofen (the active ingredients of Levocarnitine and Profen, respectively), and Levocarnitine and Profen (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Rashes and drugs of ingredients of erythromycin ethylsuccinate; sulfisoxazole acetyl - 3 seconds ago
- Could Lorazepam cause International Normalised Ratio Increased? - 3 seconds ago
- Eosinophil Count Increased and drugs of ingredients of enoxaparin sodium - 10 seconds ago
- How effective is Nabumetone for Rheumatoid Arthritis? - 14 seconds ago
- Osteoporosis Post-Menopausal and Abdominal Pain Upper - 20 seconds ago
- Coumadin and Zide drug interactions for women aged 30-39 - 28 seconds ago
- Omeprazole and Peripheral Neuropathy for Men aged 60+ - 42 seconds ago
- Omeprazole and Peripheral Neuritis for Men aged 60+ - 42 seconds ago
- Omeprazole and Neuropathy - Peripheral for Men aged 60+ - 42 seconds ago
- Omeprazole and Neuritis - Peripheral for Men aged 60+ - 43 seconds ago